Latest Insider Transactions at Forma Therapeutics Holdings, Inc. (FMTX)
This section provides a real-time view of insider transactions for Forma Therapeutics Holdings, Inc. (FMTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Forma Therapeutics Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Forma Therapeutics Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 26
2021
|
David N Cook SVP, Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+36.09%
|
-
|
|
Feb 26
2021
|
Mary E. Wadlinger Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,630
+8.1%
|
-
|
|
Feb 26
2021
|
Jeannette Potts Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,630
+35.17%
|
-
|
|
Dec 30
2020
|
Jeannette Potts Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,400
+50.0%
|
$17,000
$5.05 P/Share
|
|
Jun 23
2020
|
Steven Edward Hall Director |
BUY
Conversion of derivative security
|
Indirect |
2,106,828
+46.71%
|
-
|
|
Jun 23
2020
|
Ra Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
4,000,000
+30.74%
|
$80,000,000
$20.0 P/Share
|
|
Jun 23
2020
|
Ra Capital Management, L.P. Director |
BUY
Conversion of derivative security
|
Indirect |
5,011,651
+50.0%
|
-
|